OUTCOME OF BOARD MEETING

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹19.73

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-1.1% vs market

Pharmaceuticals peers, median of 147sector-0.8%-1.1% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-0.8-1.1-0.8-1.1

Next day

-6.8-0.7-6.1-0.6-6.2

-6.7-0.6-6.1-0.3-6.5

-2.1+0.0-2.1-0.5-1.6

+2.8-0.8+3.6-0.6+3.4

+4.9+0.7+4.1-0.9+5.7

+13.0+1.9+11.2-0.1+13.1

15d

+30.0+0.9+29.1-0.8+30.8

+26.0+1.7+24.3-1.0+26.9

+11.5+0.2+11.3-1.3+12.8

+24.2+0.8+23.4-4.7+28.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Beryl Drugs Ltd's Board of Directors held its 02/2025-2026 meeting on 7th August 2025 at the registered office in Indore. The Board approved the Unaudited Financial Results for the quarter ended 30th June 2025 (Q1 FY26). The Limited Review Report by the statutory auditors on these results was also taken on record. No specific financial figures, commentary on performance, or deviations were disclosed in this outcome filing.

Likely market impact

This is a routine regulatory disclosure confirming the Board's approval of Q1 FY26 results and the auditors' limited review. No material impact on shareholders until the actual financial numbers are examined separately.